As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
Healthcare Real Estate: Responding to Shifting Patient Demands
Over 40% of Workers Impacted by Seasonal Depression
Archer Property Partners Acquires Medical Office Building Near Tri-City Hospital
The OR HVAC Puzzle: Why Individual Systems Are on the Rise
Sutter Health Announces Plans for New Santa Clara Medical Center